Industry News

Wyeth Pharmaceuticals has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by FDA.

Aesica has appointed Chris Gowland as Chief Operating Officer, a new position created to further enhance the company's operational performance in APIs and formulated product manufacturing services.

Kemwell Biopharma announced that it has acquired Cirrus Pharmaceuticals Inc., a contract development services company based in Research Triangle Park, N.C.

The Muller Group has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions.

Aptuit has announced that Maurizio Denaro has assumed responsibilities as general manager of The Aptuit Center for Discovery & Development in Verona, Italy.

Charles River has established partnerships with Target Health Inc. and Theorem Clinical Research Inc.

Zeiss announced the acquisition of U.S.-based Xradia, Inc.

Acquisition database helps extend product lifecycle by seeking new applications for drugs.

Life Technologies Corporation has filed a definitive proxy statement with the US Securities and Exchange Commission regarding Thermo Fisher Scientific Inc.

Bashir Hansraj appointed as Global Technical Director, and David Ross and Sven Thomas appointed as business development managers

Molecular Profiles has opened a new clinical manufacturing facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency.

Penn Pharma has announced plans to invest in additional tablet manufacturing and coating capacity.

Almac's Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.

Molecular Profiles has opened a new facility in the UK following official approval from MHRA.

The facility, which includes state-of-the-art formulation, analytical and synthetic laboratories as well as a customer training center, will focus on bioavailability enhancement and oral dosage formulations.

Report outlines recommended practices for control and evaluation of operations.

Research will focus on cancer and viral disease targets not addressable using antibody-based technologies.

Parexo Labs, a division of Azaya, launches as a new CDMO with an emphasis on nanotechnology and liposomal manufacturing.

Resource will foster innovation in DEM simulation for process industries.

The core DNA-sequencing technology is based on the concept of passing a single strand of DNA through a nanometer-scale pore and reading out the sequence directly as it does so.

Almac introduces handling and bottling capabilities in EU and US headquarters.

The move doubles the CRO’s capacity in Europe.

The partnership provides access to Xencor’s Fc engineering patents for monoclonal antibodies.

Agilent Technologies Inc. introduced the MassHunter BioConfirm application, which allows users to rapidly create targeted screening methods.

Bruker Chemical and Applied Markets offers three LC-triple quadrupole (LC-TQ) mass spectrometers, the EVOQ Qube, the EVOQ Elite, and the EVOQ Elite ER.

Waters Corporation introduced the Waters SYNAPT G2-Si Mass Spectrometer, which integrates a third dimension of resolution and separation power.

Thermo Fisher Scientific Inc. has introduced a new-generation triple quadrupole liquid chromatography-mass spectrometry (LC-MS) platform.

Mettler Toledo's global weighing standard, GWP, can help pharmaceutical manufacturers meet the new requirements of USP Chapter 41 and Chapter 1251.

Hermes Pharma announced that the company completed a successful inspection by the US FDA of its production facility located in Wolfratshausen, Germany.

Thermo Fisher Scientific Inc. introduced the Thermo Scientific Orbitrap Fusion Tribrid liquid chromatography-mass spectrometry (LC-MS) system, which combines three mass analyzers.